Charmacy Pharmaceutical Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Charmacy Pharmaceutical Co Ltd with three other
drug stores in Asia:
sales of 2.82 billion Malaysian Ringgits [US$653.66 million]
Jiangsu Nhwa Pharmaceutical Company Limited
(4.15 billion Chinese Renmimbi [US$582.11 million]
of which 69%
was Medical Industrial Manufacturing), and
Zhejiang Zhenyuan Co., Ltd.
based in CHINA
(3.24 billion Chinese Renmimbi [US$454.98 million]
of which 74%
was Medicine Wholesales).
During the year ended December of 2019, sales at
Charmacy Pharmaceutical Co Ltd were HK$3.96 billion (US$510.54 million).
decrease of 14.9%
versus 2018, when the company's sales were HK$4.65 billion.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Charmacy Pharmaceutical Co Ltd had sales
of HK$3.79 billion.